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SUMMARY 
The interaction of ATP with both iron-sulfur proteins of  nitrogenase f rom 
Clostridium pasteurianum, azoferredoxin and molybdoferredoxin, has been studied 
by low-temperature EPR spectroscopy. ATP in the presence of Mg 2+ changes the 
rhombic EPR signal of  azoferredoxin with g-values of  2.06, 1.94 and 1.87 to an 
axial signal, with g values of  2.04 and 1.93. The binding of two molecules of  ATP 
per azoferredoxin dimer (mol, wt 55000) is suggested. Comparative data with other 
purine and pyrimidine nucleotides and ATP analogues demonstrate the involvement 
of  structural elements of  the substrate in the conversion of the EPR signal of  azo- 
ferredoxin. A similar effect is induced by 5 M urea, which suggests that ATP causes 
a conformation change of the protein. In contrast, no effect of  ATP was observed 
on the EPR signal of  molybdoferredoxin. 
INTRODUCTION 
Nitrogenase-catalyzed electron transport  from a reductant to dinitrogen depends 
upon the hydrolysis of  ATP 1- 3 and both components of  the enzyme, azoferredoxin 
(iron protein) and molybdoferredoxin (molybdenum-iron protein) are required 4. 
Several suggestions have been made to explain the energy requirement for the re- 
duction of  dinitrogen to ammonia.  Mortenson z proposed an activation of  reduced 
nitrogenase by ATP which subsequently would reduce dinitrogen directly. The Du 
Pont group 5'6 postulated an electron activation by ATP to form a metal hydride 
with a molybdenum phosphate or molybdenum-ATP intermediary complex. It  
was suggested that this complex reduced dinitrogen at a site containing iron and 
molybdenum. Other possibilities discussed were an ATP-dependent formation of  
hydrated electrons 7 and ATP as a proton source (H. Brintzinger, in ref. 8). Bulen 
et al. 9 proposed a model for nitrogenase in which ATP induced a conformation 
* Presented in part at the Metalloenzymes Conference of the British Biophysical Society, 
Oxford, 4-7 September, 1972. 
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change of  the protein at the substrate binding site. Such a change of  the enzyme 
should lead to a stretching and consequently facilitate reduction of the nitrogen 
molecule. Most of the above mentioned hypotheses, although unproven because of  
the lack of experimental data, assume that the ATP-interacting site of nitrogenase 
is close to the substrate (N2) binding site, presumably the molybdenum-iron protein. 
Gel filtration studies by Bui and Mortenson 1° indicated a binding of ATP 
and ADP to azoferredoxin but not to molybdoferredoxin. As a conclusion the 
interaction of  an ATP-azoferredoxin complex with a Nz-molybdoferredoxin com- 
plex was postulated. The validity of  the binding of  ATP to azoferredoxin was ques- 
tioned by Biggins and Kelly 11 who found an equal binding of  ATP to the iron 
protein and molybdenum-iron protein of Klebsiella by a similar technique to that 
previously used 1°. No binding at all was demonstrable by equilibrium dialysis 1~. 
In the present paper, which is part of  a series of electron paramagnetic resonance 
investigations on nitrogenase from CIostridium pasteurianum 12'13 we employed EPR 
as a probe to study qualitatively the interaction of ATP with azoferredoxin and 
molybdoferredoxin. The results support some previous findings from this laboratory 
and yield new insight in the mechanism of nitrogenase. A preliminary report has 
appeared ~4. 
EXPERIMENTAL 
Azoferredoxin and molybdoferredoxin were prepared by a modified method 15 
and had specific activities of  2200 and 2300 nmoles acetylene reduced per min per 
mg protein, respectively. EPR spectra were recorded at 23 °K with a Varian V45b0 
spectrometer 12. Molybdoferredoxin solutions contained approx. 40 mg protein/ml 
and were 0.05 M in Tris-HC1 buffer (pH 7.5), 1 mM in Na2S204 and 0.2 M in 
KCI. Azoferredoxin with ~ concentration of 20 to 30 mg protein/ml buffer was 0.25 
M with respect to NaC1. Protein concentrations were estimated by the biuret method 
of  Gornall et al. 16. The protein sample added to the EPR tube had a volume of  
0.3 ml and nucleotides were added to make the final concentration 10 raM. Prior 
to thawing and making additions, the tubes were refilled with deoxygenated argon 
or nitrogen gas. This precaution is necessary since air is admitted through the serum 
cap during freezing of the tube and oxidation of the thawed proteins can result. 
ATP, ADP, AMP, UTP, CTP, GTP and NAD were of the highest available purity 
(Sigma Chemical Co.) and were dissolved in 1 M Tris-HC1 (pH 8.0). ~,fl-Methylene 
ATP and fl,~,-methylene ATP were purchased from Miles Laboratories. Urea 
(Schwarz-Mann, ultra pure) was dissolved in 0.05 M Tris-HC1 (pH 7.5). A molecular 
weight of  55000 for azoferredoxin was used for calculations 17. 
RESULTS AND DISCUSSION 
Effect o f  A TP on azoferredoxin 
The EPR spectrum of dithionite-reduced azoferredoxin (Fig. 1A) approximates 
a rhombic 1.94-type signal with g values of 2.06, 1.94 and 1.87. A small line is still 
present at g=4 .3  (ref. 12). Upon addition of  MgC12 and ATP in a molar ratio of 
one (Fig. 1B) the spectrum undergoes substantial changes in line shape. However, 
the integrated intensity still accounts for 0.2 mole of  electrons per mole of protein 
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Fig. 1. Effect of ATP on the EPR spectrum of azoferredoxin (AzoFd) and molybdoferredoxin 
(MoFd). A, azoferredoxin 36 mg/ml in 0.05 M Tris-HC1 (pH 7.5), 0.25 M with respect to NaC1 
and 1 mM in Na2S204; no change in the spectrum after addition of MgC12 (10 mM) or ATP 
(10 mM) alone; B, like A after addition of MgATP; C, molybdoferredoxin 42 mg/ml in buffer 
containing 0.2 M KCI, spectrum recorded in the presence or absence of MgATP (10 raM). Sweep 
rate 500 G/rain, time constant 0.3 s; gain 50, modulation amplitude 4.5 G, frequency 9.22 GHz, 
microwave power 3 mW, temperature 23 °K, Varian standard cavity. 
of activity 2200, a number identical with that of reduced azoferredoxin without 
MgATP *t2. Despite the rather high specific activity of  azoferredoxin the possibility 
that the preparation contains only 20% of an active electron carrier species has to 
be seriously considered. After the addition of MgATP the signal of azoferredoxin 
is nearly axial with g values of 1.93 and 2.04. The signal amplitude has decreased 
by approx. 22%. The g=4 .3  resonance intensity increases but its shape appears to 
be identical to the untreated control. The effect is specific for the magnesium complex 
of ATP. The addition of  ATP or MgC1 z alone is ineffective (Fig. 1A). The order of  
addition of  ATP and Mg z+ (or both simultaneously) to azoferredoxin is without 
importance. Because oxidized azoferredoxin does not possess an EPR signal t3, these 
* Although under the conditions employed the magnesium-ATP complex exists negatively 
charged (MgATP 2-) we use throughout the paper the simpler notation (MgATP). 
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observations are restricted to the reduced form of  the protein. A kinetic study of 
the signal change bymeans  of  a rapid quench technique 13 indicates a half  time between 
10 and 40 ms. 
The requirement for magnesium ions in addition to ATP to produce the change 
in the EPR spectrum of  azoferredoxin agrees with the previous finding that Mg 2+ 
is required for nitrogenase activity even in the absence of  an ATP-generating system ~8. 
Bui and Mortenson I° also showed that Mg 2+ was required for the binding of ATP 
to azof~rredoxin. 
Effect o f  ATP on molybdoferredoxin 
The EPR spectrum of molybdoferredoxin remains the same both in the g = 4  
and g = 2  region after addition of  ATP, Mg 2+ or MgATP (Fig. 1C). 
Titration o.f azoferredoxin with ATP 
The amount of  MgATP necessary to convert the signal of  azoferredoxin to 
the MgATP form was determined by the addition of  increasing quantities of  the 
nucleotide. In order to avoid complications during the thawing and refreezing of  
the extremely oxygen sensitive protein, each ti tration point was obtained separately 
and corrected for dilution. Fig. 2 shows the plot of  the decreasing signal height 
versus the relative amount  of  MgATP added, together with EPR recordings of  3 
samples from which the points were obtained. Two intermediary states (B and C) 
show the successive decrease of  the amplitude of  the signal(s), the disappearance of  
the g =  1.87 resonance and the gradual appearance of  the g=2 .04  resonance. The 
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Fig. 2. Titration of the azoferredoxin g= 1.94 resonance with MgATP. 102 nmoles of azoferredoxin 
were titrated with a 0.1 M MgATP solution. Each point was obtained with a separate EPR tube 
and corrected for dilution. A, spectrum of the initial state indicating the type of spectral change; 
the maximal signal amplitude was used for the measurements; B, state with an ATP/protein 
molar ratio of 1.0; C, state with an ATP/protein molar ratio of 1.8. For final state see Fig. lB. 
Spectrometer settings as in Fig. 1. 
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(mol. wt 55000). Two separate sets of experiments yielded values of 1.6 and 1.8. 
It is interesting to compare these values obtained by monitoring a physical property 
of the protein with previous data of Moustafa and Mortenson la. These authors have 
shown that a Hill plot using initial reaction rates and varying the ATP concentration 
from 2 to 10 mM, gave a slope of 1.9. This number can be interpreted as the number 
of substrate binding sites and agrees with the EPR titration which indicates the binding 
of two molecules of MgATP per azoferredoxin. 
Specificity of the signal change 
We have investigated the specificity of the effect of MgATP on azoferredoxin. 
The nucleotides AMP, CTP, UTP, and NAD, either in the presence or absence 
of Mg z+ do not produce any change in the EPR spectrum of azoferredoxin (Fig. 
3A). Addition of inorganic phosphate or pyrophosphate is equally ineffective. 
Guanosine triphosphate (Fig. 3B) caused a decline of approx. 25% of the signal 
intensity and produced a spectrum somewhat intermediate between the reduced form 
and the MgATP form of azoferredoxin. However, all these nucleotides are ineffective 
in the nitrogenase assay 18' 19. The observed weak interaction of GTP with azoferred- 
oxin suggests that GTP might inhibit nitrogenase and corresponding experiments 
are in progress. 
Interestingly MgADP produces the same change in the EPR spectrum as 
MgATP (Fig. 3C) whereas ADP alone is ineffective. We also have tested the effect 
of two ATP analogues, 0qfl-methylene ATP (I) and fl,7,-methylene ATP (II) on the 
EPR spectrum of azoferredoxin. 
O O O 
Adenosine-5'-P,-CH2-P~-O-P~-OH (I) 
I I I 
OH OH OH 
O O O 
Adenosine-5'-P~-O-Pt~-CH2-Pr-CH (II) 
I I I 
OH OH OH 
Addition of either analogue (I, II) caused no signal change in the g = 2 region but 
yields a pronounced split signal at g--4.3 (Fig. 4B, cf also Fig. 1B). Upon addition 
of magnesium ions, changes identical to those caused by MgATP or MgADP were 
observed only with Compound II but not with Compound I (Fig. 4C). 
That structural features of ATP, ADP and analogue (II) cause these signal 
changes is obvious. Common to the effective compounds are the purine and pentose 
rings and the ~,fl-anhydridic diphospho bond. These elements need to be in a proper 
spacial arrangement which probably explains the requirement of Mg 2+. The ATP 
and ADP molecules have an intrinsic tendency to fold the phosphate chain towards 
the adenine ring 2°,21. Mg 2+ binds either to the fl-and ~,-phosphates of ATP or the 
~- and fl-phosphates of ADP 22, but there is no direct metal ion-adenine ring inter- 
action 22-24. However, recently the formation of an outer-sphere type metal-ATP 
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Fig. 3. Effect of various purine and pyrimidine nucleotides on the EPR spectrum of azoferredoxin 
Azoferredoxin concentration 25.4 mg/ml; final nucleotide concentration 10 raM. A, control or 
after addition of AMP, UTP, CTP or NAD in the presence or absence of Mg2+; B, after addition 
of MgGTP; C, after addition of Mg 2+ and ADP. Gain 100, other settings as in Fig. 1. 
complex has been demonstrated for manganese-ATP 24. It  is likely that this is also 
true for the MgATP complex. We assume that such a structure is necessary for a 
nucleotide to interact with azoferredoxin. In the case of  AMP and N A D  no complex 
formation would be possible. Guanosine triphosphate, whose structure is close to 
that of  adenosine triphosphate shows a weak interaction with azoferredoxin. This 
behaviour most likely can be explained by substitution of  the amino group in position 
6 by oxygen and introduction of an amino group in position 2 which alters the affinity 
of  the purine ring to its binding site on azoferredoxin and/or changes the folding 
of  the phosphate chain. The terminal phosphate group with its high bond energy 
is not required for the conversion of  the signal since MgADP and the fl,~,-methylene 
MgATP also cause the effect. For the ~,/%methylene ATP, the P~-C-Pfl bond angle 
because it is smaller than the P~-O-Pfl  bond angle may prevent proper  folding of  
the molecule, which then is excluded f rom the binding site at the protein. 
Although most of  the interpretation assumes the interaction of  a metal ion -  
ATP complex with the protein, the experiments described here have not been designed 
to rule out the formation of  a metal-protein complex z5 which might be the active 
form and specifically bind certain nucleotides. 
Ef fec t  o f  urea 
A possible explanation of  what causes the change in the EPR spectrum of  
azoferredoxin comes f rom an observation of  the effect o f  protein denaturating agents. 
Figs. 5A and 5B show the EPR spectra of  molybdoferredoxin and azoferredoxin in 
the presence of  5 M and 0.5 M urea, respectively. As one would expect the signal 
of  molybdoferredoxin disappears because of  unfolding of  the protein chain and 
distortion of  the i ron-sulfur  centre(s). The signal of  azoferredoxin even disappears 
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Fig. 4. Effect of ATP analogues on the EPR spectrum of azoferredoxin. Azoferredoxin concen- 
tration 25.4 mg/ml, final nucleotide concentration 1.65 mM; A, azoferredoxin without addition; 
B, azoferredoxin plus ~,fl-methylene ATP with or without magnesium or also plus fl,7-methylene 
ATP without magnesium; C, azoferredoxin plus magnesium salt of fl,~-methylene ATP. Spectro- 
meter settings as in Fig. 1. 
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Fig. 5. EPR spectra of molybdoferredoxin and azoferredoxin in the presence of urea. A, 31 
mg/ml molybdoferredoxin in 5 M urea; B, 10 mg/ml azoferredoxin in 0.5 M urea; 10 mg/ml 
azoferredoxin in 5 M urea. NaC1 concentration in A, 0.1 M; in B and C, 0.125 M. Spectrometer 
settings as in Fig. 1. 
at 0.5 M urea. Surprisingly however,  in the presence o f  5 M urea the EPR spectrum 
o f  azoferredoxin is virtually the same as in the presence o f  M g A T P  (Fig. 5C). A n  
intriguing explanat ion for this p h e n o m e n o n  is that azoferredoxin in 5 M urea under- 
goes a conformat ion  change which leads to a different arrangement o f  the i r o n -  
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sulfur centre(s) and which is demonstrable by the change in the EPR spectrum. A 
similar or identical conformation change of the protein would then have to be assumed 
for the effects of  MgATP, MgADP and the magnesium salt of  fl,7-methylene ATP. 
At the moment  it is not clear what causes the differential effect between the 
final urea concentration of  0.5 and 5 M. Investigations with spinach ferredoxin 26 
emphasized the importance of the ionic strength of the solvent in such experiments. 
Therefore it is likely that the 0.125 M NaC1 present with azoferredoxin cannot be 
disregarded and more systematic investigations are in progress. 
The results presented here show that MgATP interacts with azoferredoxin and 
suggest that it does not inter~tct with molybdoferredoxin. It  is generally assumed that 
the dinitrogen binding site is on the molybdenum-iron protein. However, in contrast 
to the majority of  the nitrogenase reaction models a direct involvement of  MgATP 
at a substrate binding site on molybdoferredoxin is unlikely. The signal change of 
the EPR spectrum of azoferredoxin is induced by ATP, ADP and the fl,9,-methylene 
ATP and requires in each case Mg 2+. Interestingly both the activator (ATP) and 
inhibitor (ADP) of  the nitrogenase reaction have the same effect on the EPR spectrum 
of  the protein. 
We propose that this effect is a conformational change in analogy to the EPR 
spectrum of  azoferredoxin in the presence of  urea. Measurements of  the ultraviolet 
absorption and circular dichroism of  azoferredoxin should yield more evidence for 
this assumption. It  is possible that the site(s) on azoferredoxin that interacts with 
ATP or ADP is regulatory or allosteric. There is no doubt that the conversion of 
the EPR signal of  azoferredoxin is physiologically significant because the same ob- 
servation was made with a catalytically active nitrogenase using either protons or 
acetylene as substrate 13. 
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